The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
Enrico Derenzini(The University of Texas MD Anderson Cancer Center), Anas Younes(Memorial Sloan Kettering Cancer Center)
Cited by 70
Related Papers
Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors
|Clinical Cancer Research|2004|109
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
|Blood|2008|103
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
|Oncotarget|2017|67